3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Gynecologic
1
Conditions
Head and Neck Neoplasms
2
Uterine Cervical Neoplasms
1
Lymphedema
1
Fibrosis
1
Agnosia
1
Interventions
Cisplatin
68
Paclitaxel
32
Radiotherapy
31
Carboplatin
23
Bevacizumab
21
pembrolizumab
20
Brachytherapy
18
atezolizumab
11
camrelizumab
10
Nivolumab
10
Gemcitabine
10
Drug Therapy
9
tislelizumab
8
Topotecan
8
Taxes
8
Chemoradiotherapy
8
Radiation
7
Docetaxel
7
Albumin-Bound Paclitaxel
7
zimberelimab
6
toripalimab
6
nimotuzumab
6
Magnetic Resonance Spectroscopy
6
Cetuximab
6
lenvatinib
5
durvalumab
5
dostarlimab
5
Platinum
5
Papillomavirus Vaccines
5
Injections
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Uterine Cervical Neoplasms
×
Ketoprofen
×
Clear all
NCT02439034
2026-03-16
KETOCOL
Centre Oscar Lambret
Phase 2
Completed
68 enrolled